Novo Nordisk is seeking novel cell delivery solutions to improve cell therapy treatments in humans. Specifically, the team is interested in device, biomaterial and formulation approaches to improve efficacy in Type 1 Diabetes, Chronic Heart failure and Parkinson’s Disease.
Approaches of Interest:
Biotech Asset
Spinout Company
Research Project
Centre of Excellence
Academic Researcher
Technology
Biotech Asset
Spinout Company
Research Project
Centre of Excellence
Academic Researcher
Technology
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.